Objective Rheumatoid arthritis (RA) is associated with accelerated atherosclerosis. The
reduction in cardiovascular risk that is induced by methotrexate (MTX) and anti–tumor necrosis …

Objective: To determine whether the presence of anti-cyclic citrullinated peptide (anti-CCP)
antibodies and rheumatoid factor immunoglobulin M (RF IgM) is associated with endothelial …

Background Inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis
(AS) and psoriatic arthritis (PsA), leads to increased cardiovascular disease occurrence …

Objective To examine the effect of methotrexate (MTX) with or without tumour necrosis factor
alpha (TNF-α)-inhibitors on serum lipoprotein (a)(s-Lp (a)), and to explore a possible …

The endothelial glycocalyx (EG) is essential for proper function of the endothelium and for
vascular integrity, but its role in premature atherogenesis in rheumatoid arthritis (RA) has not …

Background The complement system is involved in pathogenesis of cardiovascular disease,
and might play a role in accelerated atherogenesis in spondylarthropathies (SpA). Hence, …

Background Pentraxin 3 is proposed to be a marker of inflammation and cardiovascular risk,
but its role in inflammatory rheumatic diseases (IRDs) is still uncertain. Therefore, we …

Background The complement system plays an important role in pathophysiology of
cardiovascular disease (CVD), and might be involved in accelerated atherogenesis in rheumatoid …

Background Patients with autoimmune arthritis (AA) are at increased risk for impaired
cardiac function and heart failure. This may be partly due to the effect of inflammation in heart …

Spondyloarthropathies (SpA) are associated with increased cardiovascular risk. Among
possible mechanisms is the dysfunction of serum lipoproteins in regulating cell cholesterol …